rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1998-10-22
|
pubmed:abstractText |
The purpose of this study was to assess the benefit of combined CT and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in diagnosing malignancy.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0361-803X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
171
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1103-10
|
pubmed:dateRevised |
2008-2-15
|
pubmed:meshHeading |
pubmed-meshheading:9763005-Abdominal Neoplasms,
pubmed-meshheading:9763005-Female,
pubmed-meshheading:9763005-Fluorine Radioisotopes,
pubmed-meshheading:9763005-Fluorodeoxyglucose F18,
pubmed-meshheading:9763005-Humans,
pubmed-meshheading:9763005-Male,
pubmed-meshheading:9763005-Middle Aged,
pubmed-meshheading:9763005-Neoplasm Recurrence, Local,
pubmed-meshheading:9763005-Predictive Value of Tests,
pubmed-meshheading:9763005-ROC Curve,
pubmed-meshheading:9763005-Radiopharmaceuticals,
pubmed-meshheading:9763005-Retrospective Studies,
pubmed-meshheading:9763005-Sensitivity and Specificity,
pubmed-meshheading:9763005-Thoracic Neoplasms,
pubmed-meshheading:9763005-Tomography, Emission-Computed,
pubmed-meshheading:9763005-Tomography, X-Ray Computed
|
pubmed:year |
1998
|
pubmed:articleTitle |
Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.
|
pubmed:affiliation |
Department of Radiology, University of Washington School of Medicine, Seattle 98195-7115, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|